218 related articles for article (PubMed ID: 34629057)
1. Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice.
Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
Lipids Health Dis; 2021 Oct; 20(1):135. PubMed ID: 34629057
[TBL] [Abstract][Full Text] [Related]
2. Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease.
Haberl EM; Pohl R; Rein-Fischboeck L; Höring M; Krautbauer S; Liebisch G; Buechler C
Lipids Health Dis; 2020 Dec; 19(1):250. PubMed ID: 33298075
[TBL] [Abstract][Full Text] [Related]
3. Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinoma.
Krautbauer S; Meier EM; Rein-Fischboeck L; Pohl R; Weiss TS; Sigruener A; Aslanidis C; Liebisch G; Buechler C
Biochim Biophys Acta; 2016 Nov; 1861(11):1767-1774. PubMed ID: 27570113
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma.
Haberl EM; Pohl R; Rein-Fischboeck L; Feder S; Sinal CJ; Bruckmann A; Hoering M; Krautbauer S; Liebisch G; Buechler C
Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905933
[TBL] [Abstract][Full Text] [Related]
5. [(11)C]acetate PET Imaging is not Always Associated with Increased Lipogenesis in Hepatocellular Carcinoma in Mice.
Li L; Che L; Wang C; Blecha JE; Li X; VanBrocklin HF; Calvisi DF; Puchowicz M; Chen X; Seo Y
Mol Imaging Biol; 2016 Jun; 18(3):360-7. PubMed ID: 26567114
[TBL] [Abstract][Full Text] [Related]
6. Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma.
Haberl EM; Weiss TS; Peschel G; Weigand K; Köhler N; Pauling JK; Wenzel JJ; Höring M; Krautbauer S; Liebisch G; Buechler C
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069902
[TBL] [Abstract][Full Text] [Related]
7. High Serum Levels of Cholesterol Increase Antitumor Functions of Nature Killer Cells and Reduce Growth of Liver Tumors in Mice.
Qin WH; Yang ZS; Li M; Chen Y; Zhao XF; Qin YY; Song JQ; Wang BB; Yuan B; Cui XL; Shen F; He J; Bi YF; Ning G; Fu J; Wang HY
Gastroenterology; 2020 May; 158(6):1713-1727. PubMed ID: 31972238
[TBL] [Abstract][Full Text] [Related]
8. Fructose-1,6-Bisphosphate Aldolase B Depletion Promotes Hepatocellular Carcinogenesis Through Activating Insulin Receptor Signaling and Lipogenesis.
Liu G; Wang N; Zhang C; Li M; He X; Yin C; Tu Q; Shen X; Zhang L; Lv J; Wang Y; Jiang H; Chen S; Li N; Tao Y; Yin H
Hepatology; 2021 Dec; 74(6):3037-3055. PubMed ID: 34292642
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-148a deficiency promotes hepatic lipid metabolism and hepatocarcinogenesis in mice.
Cheng L; Zhu Y; Han H; Zhang Q; Cui K; Shen H; Zhang J; Yan J; Prochownik E; Li Y
Cell Death Dis; 2017 Jul; 8(7):e2916. PubMed ID: 28703810
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.
Chang W; He W; Li PP; Song SS; Yuan PF; Lu JT; Wei W
Eur J Pharmacol; 2016 Aug; 784():173-80. PubMed ID: 27181068
[TBL] [Abstract][Full Text] [Related]
11. PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis.
Bhalla K; Hwang BJ; Dewi RE; Ou L; Twaddel W; Fang HB; Vafai SB; Vazquez F; Puigserver P; Boros L; Girnun GD
Cancer Res; 2011 Nov; 71(21):6888-98. PubMed ID: 21914785
[TBL] [Abstract][Full Text] [Related]
12. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C
J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671
[TBL] [Abstract][Full Text] [Related]
13. The aryl hydrocarbon receptor activates ceramide biosynthesis in mice contributing to hepatic lipogenesis.
Liu Q; Zhang L; Allman EL; Hubbard TD; Murray IA; Hao F; Tian Y; Gui W; Nichols RG; Smith PB; Anitha M; Perdew GH; Patterson AD
Toxicology; 2021 Jun; 458():152831. PubMed ID: 34097992
[TBL] [Abstract][Full Text] [Related]
14. Molecular profiling of hepatocellular carcinomas developing spontaneously in acyl-CoA oxidase deficient mice: comparison with liver tumors induced in wild-type mice by a peroxisome proliferator and a genotoxic carcinogen.
Meyer K; Lee JS; Dyck PA; Cao WQ; Rao MS; Thorgeirsson SS; Reddy JK
Carcinogenesis; 2003 May; 24(5):975-84. PubMed ID: 12771043
[TBL] [Abstract][Full Text] [Related]
15. The Adenosine Monophosphate (AMP) Analog, 5-Aminoimidazole-4-Carboxamide Ribonucleotide (AICAR) Inhibits Hepatosteatosis and Liver Tumorigenesis in a High-Fat Diet Murine Model Treated with Diethylnitrosamine (DEN).
Gao J; Xiong R; Xiong D; Zhao W; Zhang S; Yin T; Zhang X; Jiang G; Yin Z
Med Sci Monit; 2018 Nov; 24():8533-8543. PubMed ID: 30474622
[TBL] [Abstract][Full Text] [Related]
16. Hepatic peroxisome proliferator-activated receptor γ coactivator 1β drives mitochondrial and anabolic signatures that contribute to hepatocellular carcinoma progression in mice.
Piccinin E; Peres C; Bellafante E; Ducheix S; Pinto C; Villani G; Moschetta A
Hepatology; 2018 Mar; 67(3):884-898. PubMed ID: 28857232
[TBL] [Abstract][Full Text] [Related]
17. Constitutive Notch2 signaling induces hepatic tumors in mice.
Dill MT; Tornillo L; Fritzius T; Terracciano L; Semela D; Bettler B; Heim MH; Tchorz JS
Hepatology; 2013 Apr; 57(4):1607-19. PubMed ID: 23175466
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model.
El-Ahwany E; Mansy SS; Zoheiry M; Mourad L; Mahmoud S; Abu-Taleb H; Hassanien M; Hassan M
Ultrastruct Pathol; 2020 Mar; 44(2):203-210. PubMed ID: 32216509
[No Abstract] [Full Text] [Related]
19. Diagnostic Value of Systemic Cholesteryl Ester/Free Cholesterol Ratio in Hepatocellular Carcinoma.
Krautbauer S; Weiss TS; Wiest R; Schacherer D; Liebisch G; Buechler C
Anticancer Res; 2017 Jul; 37(7):3527-3535. PubMed ID: 28668842
[TBL] [Abstract][Full Text] [Related]
20. Regulation of accumulation and function of myeloid derived suppressor cells in different murine models of hepatocellular carcinoma.
Kapanadze T; Gamrekelashvili J; Ma C; Chan C; Zhao F; Hewitt S; Zender L; Kapoor V; Felsher DW; Manns MP; Korangy F; Greten TF
J Hepatol; 2013 Nov; 59(5):1007-13. PubMed ID: 23796475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]